TheFiscalFinder
● Single award · grant

Randomized Double Blind, Placebo Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of…

A single federal award, with both ends of the trail linked.
$64.2M
total award value
2020
action date
83 mo
period
R01AG065248
FAIN
Agency ›
Department of Health and Human Services
✓ from source
awarded→$64.2M
State ›
Pennsylvania
✓ from source

Description

Randomized Double Blind, Placebo Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease Over 18 Months

Awarding agencyDepartment of Health and Human Services →
RecipientOutside our Phase 1 contractor set: see methodology
Place of performancePennsylvania →
Category—
Competed?Not recorded✓ from source
Total (exact)$64,236,115

More from Department of Health and Human Services

Medicaid Entitlement for 7 - Fy 2026 - T19
awarded 2024$100.1B
Medicaid Entitlement for 7 - Fy 2025 - T19
awarded 2023$92B
Medicaid Entitlement for 7 - Fy 2024 - T19
awarded 2022$80.5B
Medicaid Entitlement for 7 - Fy 2023 - T19
awarded 2021$80.5B
Medicaid Entitlement for 7 - Fy 2022 Quarter 4 - T19
awarded 2022$71.7B
All awards from this agency →
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; anything we compute or infer (corporate parents, districts, competitors) is ≈ inferred and worded carefully, never asserted as fact.